Hyperpigmentation Disorders Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
NEW YORK, August 7, 2018 /PRNewswire/ -- Global Hyperpigmentation Disorders Treatment Market: Overview
This report analyzes the global hyperpigmentation disorders treatment market in terms of its current and future scenario.Rise in investment in R&D of novel advanced technologies, decrease in social taboos regarding pigmentation, increase in prevalence of hyperpigmentation-related disorders, and rise in awareness about skin rejuvenation and treatment options are likely to drive the growth of the global market during the forecast period.
Read the full report: https://www.reportlinker.com/p05482751
Anti-pigmentation therapies can be classified as topical drugs, microdermabrasion, chemical peels, and laser therapy. These therapies are available in hospitals and aesthetic clinics & dermatology centers.
This report on the global hyperpigmentation disorders treatment market comprises an elaborate executive summary, including a market snapshot that provides information about various segments of the market.The report also provides information and data analysis of the global market with respect to its segments based on product type, application, and geography.
A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section.In addition, the section comprises competitive matrix and company profiles with business overview to project the competitive landscape of the market.
It also provides market attractiveness analysis in terms of geography, and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario prevailing in the global hyperpigmentation disorders treatment market.
Global Hyperpigmentation Disorders Treatment Market: Key Segments
The global hyperpigmentation disorders treatment market has been segmented into topical drugs, laser therapy, chemical peels, microdermabrasion, phototherapy, and others, based on treatment type.By disease indication, the market has been classified into melasma, post-inflammatory hyperpigmentation, solar lentigines, and others.
In terms of end-user, the market has been segmented into hospitals, aesthetic clinics & dermatology centers, and others.The global hyperpigmentation disorders treatment market has been analyzed based on increasing prevalence of hyperpigmentation disorders, technology trend, expenditure on emerging technologies, and presence of key players in the region.
Market size and forecast for each of these segments have been provided for the period of 2016 to 2026, along with their respective CAGR for the forecast period, i.e. from 2018 to 2026, considering 2017 as the base year.
Global Hyperpigmentation Disorders Treatment Market: Regional Outlook
Geographically, the global hyperpigmentation disorders treatment market has been categorized into five major regions and key countries in these regions: North America (the U.S., Canada), Europe (the U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC, South Africa, Israel, and Rest of Middle East & Africa). Market size and forecast for each of these regions and their key countries have been provided for the period of 2016 to 2026, along with their respective CAGR for the forecast period, viz. 2018-2026, considering 2017 as the base year. This report also covers the competitive scenario of the market in these regions.
Companies Mentioned in Report
The report profiles the major players operating in the global hyperpigmentation disorders treatment market in terms of attributes, such as, company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in this report are Bayer AG, ALLERGAN, Galderma S.A., SkinCeuticals, Pierre Fabre, EpiPharm AG, RXi Pharmaceuticals Corporation, Obagi Cosmeceuticals LLC, and Vivier Pharma.
The global hyperpigmentation disorders treatment market has been segmented as follows:
Hyperpigmentation Disorders Treatment Market, by Treatment Type
Topical Drugs
Laser Therapy
Chemical Peels
Microdermabrasion
Phototherapy
Others
Hyperpigmentation Disorders Treatment Market, by Disease Indication
Melasma
Post-inflammatory Hyperpigmentation
Solar Lentigines
Others
Hyperpigmentation Disorders Treatment Market, by End-user
Hospitals
Aesthetic Clinics & Dermatology Centers
Others
Hyperpigmentation Disorders Treatment Market, by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
Australia & New Zealand
India
Rest of Asia-pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Israel
Rest of Middle East & Africa
Read the full report: https://www.reportlinker.com/p05482751
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article